New drug trial aims to restore skin color in vitiligo patients
NCT ID NCT06905873
Summary
This study is testing an investigational drug called FB102 to see if it is safe and can help restore skin color in adults with non-segmental vitiligo. About 64 participants will be randomly assigned to receive either FB102 or a placebo (an inactive substance) for comparison. Researchers will primarily track side effects and measure changes in facial skin pigmentation over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cornerstone Dermatology
RECRUITINGCoorparoo, Queensland, 4151, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Momentum Pukehoke
RECRUITINGAuckland, Auckland, 2120, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Novatrials
RECRUITINGKotara, New South Wales, 2289, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Optimal Clinical Trials Central
RECRUITINGAuckland, Auckland, 1010, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Optimal Clinical Trials North
RECRUITINGAuckland, Auckland, 0632, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Skin & Cancer Foundation Australia - The Skin Hospital
RECRUITINGDarlinghurst, New South Wales, 2010, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.